Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Acquity Group Prices IPO Of 5.5 Mln ADS At $6/ADS - Quick Facts

RELATED NEWS
Trade AQ now with 
4/27/2012 1:25 AM ET

Acquity Group Limited (AQ: Quote) announced the pricing of its initial public offering of 5.55 million American depositary shares or "ADS" at a price to the public of $6.00 per ADS. The ADSs are expected to commence trading on the NYSE AMEX on April 27th, 2012 under the symbol "AQ."

The underwriters have an option, exercisable for 30 days from April 26th, 2012, to buy up to an additional 833,333 ADSs from the company at the initial public offering price. Citigroup Inc. and Oppenheimer & Co., Inc. acted as lead underwriters. William Blair & Company and First Analysis Securities Corp. acted as co managers in the offering.

Click here to receive FREE breaking news email alerts for Acquity Group Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Existing home sales in the U.S. saw a modest increase in the month of April, according to a report released by the National Association of Realtors on Wednesday. NAR said existing home sales climbed 0.6 percent to a seasonally adjusted annual rate of 4.97 million in April from an upwardly revised 4.94 million in March. Federal Reserve Chairman Ben Bernanke on Wednesday downplayed speculation that the central bank is planning to taper its $85 billion monthly bond buying program. The economic recovery remains too fragile to proceed without extraordinary support from the Fed in light of fiscal restraint and headwinds... Stocks have moved modestly higher in early trading on Wednesday, adding to the slim gains posted in the previous session. The major averages have all climbed into positive territory, although buying interest has remained relatively subdued. The major averages have seen some further upside in recent trading, reaching new highs for the young session.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.